S
Subramanian
About Subramanian
Data last updated:
Subramanian is a Director at Mabtree Biologics India Private Limited (since 2020) and Director at Docit Syrl India (Opc) Private Limited (since 2024). The companies operate in Life Sciences. The largest current company by reported revenue is Mabtree Biologics India Private Limited at ₹41,511 (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mabtree Biologics India Private Limited U24239TG2019PTC132087 | Director | 18 Mar 2020 | 2019 | ₹41,511 (FY 2023) | Active |
| Docit Syrl India (Opc) Private Limited U62013TN2024OPC170298 | Director | 17 May 2024 | 2024 | Active |
Board colleagues of Subramanian
| Name | DIN | Company | Designation |
|---|---|---|---|
| Alexander Ratna Monica | 08546494 | Mabtree Biologics India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subramanian
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subramanian
Subramanian currently holds 2 directorships: Mabtree Biologics India Private Limited (Director, since 18 Mar 2020, revenue ₹41,511 (FY 2023)); Docit Syrl India (Opc) Private Limited (Director, since 17 May 2024).
Subramanian was first appointed on 18 Mar 2020 as Director at Mabtree Biologics India Private Limited. The most recent appointment on record is 17 May 2024 at Docit Syrl India (Opc) Private Limited.
The current boards of Subramanian's companies include Alexander Ratna Monica (Mabtree Biologics India Private Limited).